Is blinding a possible solution to the implicit biases that exist throughout the healthcare and biomedical science fields? Christopher Robertson, a Lab affiliate and Associate Professor of Law at the University of Arizona, and former Lab Fellow Marie Newhouse examine the positives and negatives of blinding. They also discuss Robertson’s current collaborative research project on political corruption and how juror discretion affects the outcome of campaign finance cases.

The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders affects drugs with sales in the billions of dollars. In research supported by the Edmond J. Safra Center for Ethics, Lisa Cosgrove of UMass-Boston investigated financial ties between DSM panel members and the pharmaceutical companies that have a vested interest in finding new indications for their blockbuster drugs. In this podcast, she tells journalist Gregg Fields what she found, what it means—and why we all should care.

What will it take for EPA to protect people and the environment from hazardous pollutants? Closing the loopholes in the Toxic Substances Act (TSCA) would help, but industry pressure has Congress on the verge of a "reform" bill that might make things worse. Journalist Ted Gup interviews investigative reporting fellow Sheila Kaplan on institutional corruption at EPA.